Premium
O4‐11‐04: LINKING DIABETES AND ALZHEIMER'S DISEASE THROUGH RAGE: A RETROSPECTIVE ANALYSIS OF AZELIRAGON PHASE 2 AND PHASE 3 STUDIES
Author(s) -
Valcarce Carmen,
Dunn Imogene,
Burstein Aaron H.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4803
Subject(s) - medicine , placebo , post hoc analysis , rage (emotion) , diabetes mellitus , type 2 diabetes , subgroup analysis , population , gastroenterology , endocrinology , psychology , pathology , confidence interval , neuroscience , alternative medicine , environmental health
Karolinska Institutet Center for Alzheimer Research, Stockholm, Sweden; Center for Alzheimer Research and Treatment, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital, Boston, MA, USA; University of Southern California, San Diego, CA, USA; Alzheimer’s Association, Chicago, IL, USA; Institute of Clinical Medicine, Kuopio, Finland; University of Eastern Finland, Kuopio, Finland; University of California, Davis, Sacramento, CA, USA. Contact e-mail: ldbaker@wakehealth.edu